Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0012872 (
DNA marker
)
929
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Huntington's disease
(HD) is an autosomal dominant neurodegenerative disorder characterized by progressive involuntary movements and dementia. The symptoms of the disease, although devastating in severity, do not usually appear until the third to fourth decade of life. The gene defect is highly penetrant, and results in the loss of neurones in the basal ganglia, globus pallidus, and more diffusely in the cortex. A
DNA marker
, G8 (or D4S10), is tightly linked to
Huntington's disease
and this gene has been localized to chromosome 4 (ref. 3). The discovery of this linkage marker raises the possibility of developing a presymptomatic test for the disorder, and of eventually isolating the disease gene based on its map position. We have now regionally localized the
DNA marker
G8 to the terminal band of the short arm of the chromosome, a region representing approximately 0.5% of the total human genome. The assignment was made by examining DNA from patients with Wolf-Hirschhorn syndrome, a birth defect resulting from partial heterozygous deletion of the short arm of chromosome 4.
...
PMID:Deletion of Huntington's disease-linked G8 (D4S10) locus in Wolf-Hirschhorn syndrome. 299 23
Recombinant DNA technology has provided a vast new source of DNA markers displaying heritable sequence variation in humans. These markers can be used in family studies to identify the chromosomal location of defective genes causing nervous system disorders. The discovery of a
DNA marker
linked to
Huntington's disease
has opened new avenues of research into this disorder and may ultimately permit cloning and characterization of the defective gene.
...
PMID:DNA markers for nervous system diseases. 608 46
Recombinant DNA techniques have provided the means to generate large numbers of new genetic linkage markers. This technology has been used to identify a
DNA marker
that coinherits with the
Huntington's Disease
(HD) gene in family studies. The HD locus has thereby been mapped to human chromosome 4. The discovery of a genetic marker for the inheritance of HD has implications both for patient care and future research. The same approach holds considerable promise for the investigation of other genetic diseases, including Dystonia Musculorum Deformans.
...
PMID:Genetic linkage of the Huntington's disease gene to a DNA marker. 624 Mar 13
The recent finding of a closely linked
DNA marker
to the
Huntington Disease
gene allows the opportunity for prenatal and preclinical diagnosis. The methodology for using these markers for prediction in late age of onset disorders is discussed. Since these methods are both difficult and complex for the majority of genetic counselors, a simple solution is suggested. This involves using the well known linkage program LIPED and running it twice for a given consultand, once assuming he carries the gene and once that he is homozygous normal. This will allow accurate predictions for counselors with limited backgrounds in pedigree analysis.
...
PMID:Huntington disease: estimation of heterozygote status using linked genetic markers. 624 1
Family studies show that the
Huntington's disease
gene is linked to a polymorphic
DNA marker
that maps to human chromosome 4. The chromosomal localization of the
Huntington's disease
gene is the first step in using recombinant DNA technology to identify the primary genetic defect in this disorder.
...
PMID:A polymorphic DNA marker genetically linked to Huntington's disease. 631 46
My mother, Leonore, was diagnosed with
Huntington's disease
(HD) in 1968 at age 53. I was 23, my sister Alice 26, and our father, Milton Wexler, 60 years old. The same year, our father created the Hereditary Disease Foundation (HDF), dedicated to finding treatments and cures for HD. HD is an autosomal dominant, neurodegenerative disorder. Alice and I each have a 50% chance of inheriting and dying from the disorder. Over the past 43 years, we have been proud to change the face of science. Through Milton Wexler Interdisciplinary Workshops, judicious funding, and focusing on innovation and creativity, the HDF is an integral partner in key discoveries. The HDF recruited and supported >100 scientists worldwide who worked together as the
Huntington's Disease
Collaborative Research Group in a successful ten-year search for the HD gene. We found a
DNA marker
for the HD gene in 1983-the first marker to be found when the chromosomal location was unknown. We isolated the HD gene itself a decade later. These breakthroughs helped launch the Human Genome Project. We supported creating the first mouse model of HD and many other model systems. Currently, we focus on gene silencing, among other approaches, to create new treatments and cures.
...
PMID:Huntington's disease: advocacy driving science. 2224 19
<< Previous
1
2
3